Persistently Active Microbial Molecules Prolong Innate Immune Tolerance In Vivo

PLoS Pathogens

Volumn 9, Issue 5, 2013, Pages

  Lu, Mingfang ^a   Varley, Alan W ^b   Munford, Robert S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LIMIT OF QUANTITATION; MACROPHAGE; MICROARRAY ANALYSIS; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNE TOLERANCE; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA;

EID: 84878478119     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003339     Document Type: Article

References (75)

1. Cohn ZA, (1963) The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages. J Exp Med 117: 27-42.
2. Elsbach P, (1973) On the Interaction Between Phagocytes and Micro-organisms. N Engl J Med 289: 846-852.
3. Elsbach P, (1980) Degradation of Microorganisms by Phagocytic Cells. Rev Infect Dis 2: 106-128.
4. Humann J, Lenz LL, (2009) Bacterial peptidoglycan degrading enzymes and their impact on host muropeptide detection. J Innate Immun 1: 88-97.
5. Wang H, Gupta D, Li X, Dziarski R, (2005) Peptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway. Infect Immun 73: 7216-7225.
6. Royet J, Gupta D, Dziarski R, (2011) Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nat Rev Immunol 11: 837-851.
7. Seibold MA, Reese TA, Choudhry S, Salam MT, Beckman K, et al. (2009) Differential Enzymatic Activity of Common Haplotypic Versions of the Human Acidic Mammalian Chitinase Protein. Journal of Biological Chemistry 284: 19650-19658.
8. Renko J, Lepp PW, Oksala N, Nikkari S, Nikkari ST, (2008) Bacterial signatures in atherosclerotic lesions represent human commensals and pathogens. Atherosclerosis 201: 192-197.
9. Koren O, Spor A, Felin J, Fak F, Stombaugh J, et al. (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences 108: 4592-4598.
10. Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA, (2012) Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest 122: 2652-2660.
11. Cohn ZA, (1964) The fate of bacteria within phagocytic cells. III. Destruction of an Escherichia coli agglutinogen within polymorphonuclear leucocytes and macrophages. J Exp Med 120: 869-883.
12. Smialowicz RJ, Schwab JH, (1977) Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro. Infect Immun 17: 591-598.
13. Henricson BE, Manthey CL, Yu Perera P, Hamilton TA, Vogel SN, (1993) Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun 61: 2325-2333.
14. Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC, (1998) Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. Journal of Immunology 160: 3729-3736.
15. Medvedev AE, Sabroe I, Hasday JD, Vogel SN, (2006) Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 12: 133-150.
16. Ellaban E, Bolgos G, Remick D, (2004) Selective macrophage suppression during sepsis. Cell Immunol 231: 103-111.
17. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, et al. (2008) Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 205: 323-329.
18. Sato S, Takeuchi O, Fujita T, Tomizawa H, Takeda K, et al. (2002) A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and- independent pathways. Int Immunol 14: 783-791.
19. Wang JH, Doyle M, Manning BJ, Blankson S, Wu QD, et al. (2003) Bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. Journal of Immunology 170: 14-18.
20. Hedl M, Li J, Cho JH, Abraham C, (2007) Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proceedings of the National Academy of Sciences 104: 19440-19445.
21. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T, (2001) Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166: 5161-5167.
22. Mizel SB, Snipes JA, (2002) Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5. Journal of Biological Chemistry 277: 22414-22420.
23. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M, (2003) Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9: 101-107.
24. Munford R, Lu M, Varley A, (2009) Chapter 2: Kill the bacteria. and also their messengers? Adv Immunol 103: 29-48.
25. Lu M, Varley AW, Ohta S, Hardwick J, Munford RS, (2008) Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection. Cell Host Microbe 4: 293-302.
26. Thompson PA, Gauthier KC, Varley AW, Kitchens RL, (2010) ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. Journal of Lipid Research 51: 2672-2685.
27. Kitchens RL, Thompson PA, Viriyakosol S, O'Keefe GE, Munford RS, (2001) Plasma CD14 decreases monocyte responses to LPS by promoting the transfer of cell-bound LPS to plasma lipoproteins. J Clin Invest 108: 485-493.
28. Carson WF, Cavassani KA, Dou Y, Kunkel SL, (2011) Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 6: 273-283.
29. Foster SL, Hargreaves DC, Medzhitov R, (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
30. Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE, (2011) NAD+-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance. Journal of Biological Chemistry 286: 9856-9864.
31. Gazzar ME, Yoza BK, Hu JY-Q, Cousart SL, McCall CE, (2007) Epigenetic Silencing of Tumor Necrosis Factor {alpha} during Endotoxin Tolerance. Journal of Biological Chemistry 282: 26857-26864.
32. Chan C, Li L, McCall CE, Yoza BK, (2005) Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J Immunol 175: 461-468.
33. Wolk K, Hoflich C, Zuckermann-Becker H, Docke WD, Volk HD, et al. (2007) Reduced monocyte CD86 expression in postinflammatory immunodeficiency. Crit Care Med 35: 458-467.
34. Husebye H, Halaas O, Stenmark H, Tunheim G, Sandanger O, et al. (2006) Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25: 683-692.
35. Lu M, Zhang M, Kitchens RL, Fosmire S, Takashima A, et al. (2003) Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med 197: 1745-1754.
36. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, et al. (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170: 508-519.
37. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, et al. (1997) Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nature Med 3: 678-681.
38. Randow F, Döcke WD, Bundschuh DS, Hartung T, Wendel A, et al. (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-l2, and granulocyte-macrophage colony-stimulating factor. J Immunol 158: 2911-2918.
39. Munford RS, Hall CL, (1985) Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 48: 464-473.
40. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA, (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15: 496-497.
41. Reynolds CM, Ribeiro AA, McGrath SC, Cotter RJ, Raetz CRH, et al. (2006) An Outer Membrane Enzyme Encoded by Salmonella typhimurium lpxR That Removes the 3′-Acyloxyacyl Moiety of Lipid A. Journal of Biological Chemistry 281: 21974-21987.
42. Bates JM, Akerlund J, Mittge E, Guillemin K, (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2: 371-382.
43. Lu M, Zhang M, Takashima A, Weiss J, Apicella MA, et al. (2005) Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat Immunol 6: 989-994.
44. Shao B, Lu M, Katz SC, Varley AW, Hardwick J, et al. (2007) A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen. Journal of Biological Chemistry 282: 13726-13735.
45. Shao B, Kitchens RL, Munford RS, Rogers TE, Rockey DC, et al. (2011) Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology 54: 1051-1062.
46. Munford RS, (2005) Detoxifying endotoxin: time, place, and person. J Endotoxin Res 11: 69-84.
47. Ojogun N, Kuang TY, Shao B, Greaves DR, Munford RS, et al. (2009) Overproduction of acyloxyacyl hydrolase by macrophages and dendritic cells prevents prolonged reactions to bacterial lipopolysaccharide in vivo. J Infect Dis 200: 1685-1693.
48. Hume DA, Underhill DM, Sweet MJ, Ozinsky AO, Liew FY, et al. (2001) Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol 2: 11.
49. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE, (2007) Tobacco Smoking Inhibits Expression of Proinflammatory Cytokines and Activation of IL-1R-Associated Kinase, p38, and NF-κB in Alveolar Macrophages Stimulated with TLR2 and TLR4 Agonists. J Immunol 179: 6097-6106.
50. Munoz C, Carlet J, Fitting C, Misset B, Bieriot J-P, et al. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88: 1747-1754.
51. del Fresno C, Garcia-Rio F, Gomez-Pina V, Soares-Schanoski A, Fernandez-Ruiz I, et al. (2009) Potent Phagocytic Activity with Impaired Antigen Presentation Identifying Lipopolysaccharide-Tolerant Human Monocytes: Demonstration in Isolated Monocytes from Cystic Fibrosis Patients. The Journal of Immunology 182: 6494-6507.
52. McCabe WR, (1963) Endotoxin tolerance. II. Its occurrence in patients with pyelonephritis. J Clin Invest 42: 618-625.
53. Greisman SE, Hornick RB, Carozza FA Jr, Woodward TE, (1963) The role of endotoxin during typhoid fever and tularemia in man. I. Acquisition of tolerance to endotoxin. J Clin Invest 42: 1064-1075.
54. Poole JA, Romberger DJ, (2012) Immunological and inflammatory responses to organic dust in agriculture. Curr Opin Allergy Clin Immunol 12: 126-132.
55. Poole JA, Alexis NE, Parks C, MacInnes AK, Gentry-Nielsen MJ, et al. (2008) Repetitive organic dust exposure in vitro impairs macrophage differentiation and function. J Allergy Clin Immunol 122: 375-382, 382.
56. Munford RS, (2008) Sensing Gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun 76: 454-465.
57. Munford RS, Varley AW, (2006) Shield as signal: lipopolysaccharides and the evolution of immunity to Gram-negative bacteria. PLoS Pathog 2: e67.
58. Bosse Y, Bacot F, Montpetit A, Rung J, Qu HQ, et al. (2009) Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans. Human Genetics 125: 305-318.
59. Zhang Y, Endam LM, Filali-Mouhim A, Zhao L, Desrosiers M, et al. (2012) Polymorphisms in RYBP and AOAH Genes Are Associated with Chronic Rhinosinusitis in a Chinese Population: A Replication Study. PLoS ONE 7: e39247.
60. Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, et al. (2006) Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J Allergy Clin Immunol 118: 70-77.
61. Fehrmann RSN, Jansen RC, Veldink JH, Westra HJ, Arends D, et al. (2011) Trans-eQTLs Reveal That Independent Genetic Variants Associated with a Complex Phenotype Converge on Intermediate Genes, with a Major Role for the HLA. PLoS Genet 7: e1002197.
62. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, et al. (2012) Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 44: 502-510.
63. Duncan RL Jr, Hoffman J, Tesh VL, Morrison DC, (1986) Immunologic activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro. J Immunol 136: 2924-2929.
64. Kitchens RL, Thompson PA, O'Keefe GE, Munford RS, (2000) Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. J Endotoxin Res 6: 482.
65. Weinrauch Y, Katz SS, Munford RS, Elsbach P, Weiss J, (1999) Deacylation of purified LPS by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect Immun 67: 3376-3382.
66. Gioannini TL, Teghanemt A, Zhang D, Prohinar P, Levis EN, et al. (2007) Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase. J Biol Chem 282: 7877-7884.
67. Feulner JA, Lu M, Shelton JM, Zhang M, Richardson JA, et al. (2004) Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infect Immun 72: 3171-3178.
68. Shao B, Munford RS, Kitchens R, Varley AW, (2012) Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun 18: 825-833.
69. Nathan C, Ding A, (2010) Nonresolving Inflammation. Cell 140: 871-882.
70. Serhan CN, Chiang N, Van Dyke TE, (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
71. Rossi Ag, Sawatsky DA (2008) The Resolution of Inflammation. Basel: Birkhäuser Verlag Ag.
72. Morris T, Stables M, Colville-Nash P, Newson J, Bellingan G, et al. (2010) Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA 107: 8842-8847.
73. Galanos C, Luderitz O, Westphal O, (1969) A new method for the extraction of R lipopolysaccharides. Eur J Biochem 9: 245-249.
74. Hall CL, Munford RS, (1983) Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils. Proc Natl Acad Sci USA 80: 6671-6675.
75. Barth MW, Hendrzak JA, Melnicoff MJ, Morahan PS, (1995) Review of the macrophage disappearance reaction. J Leukoc Biol 57: 361-367.